Interventions to Promote Health and Increase Health Care Efficiency: December 2015 Update

Interventions to Promote Health and Increase Health Care Efficiency: December 2015 Update

Washington State Institute for Public Policy 110 Fifth Avenue SE, Suite 214 ● PO Box 40999 ● Olympia, WA 98504 ● 360.586.2677 ● www.wsipp.wa.gov December 2015 Interventions to Promote Health and Increase Health Care Efficiency: December 2015 Update The Washington State Legislature directed the Summary Washington State Institute for Public Policy (WSIPP) to “calculate the return on investment WSIPP’s Board of Directors authorized WSIPP to work on a joint project with the MacArthur Foundation and to taxpayers from evidence-based prevention the Pew Charitable Trusts to extend WSIPP’s benefit- and intervention programs and policies."1 cost analysis to certain health care topics. An important Additionally, WSIPP’s Board of Directors goal is to determine whether there are strategies that authorized WSIPP to work on a joint project can help states control Medicaid and other health care with the MacArthur Foundation and Pew costs. We consulted with Washington State legislative Charitable Trusts to extend WSIPP’s benefit- staff to identify the specific health care topics of cost analysis to certain health care topics. interest. In this report, we present our new and We present findings for four new topics: 1) hospital– updated benefit-cost results for a variety of based programs to reduce cesarean sections; 2) school-, workplace-, and community-based obesity interventions to promote health and increase prevention programs; 3) accountable care health care efficiency. We consulted with organizations; and 4) patient cost sharing. We also Washington State legislative staff to identify summarize prior findings for six topics: 1) “lifestyle” the specific health care topics of interest. programs designed to prevent diabetes; 2) behavioral interventions to reduce obesity in adults and children; In Section I we review our research approach. 3) transitional care to prevent hospital readmissions; 4) patient-centered medical homes to reduce health care In Section II we discuss new findings for four costs; 5) programs to reduce avoidable emergency topics: 1) hospital-based programs to reduce department visits; and 6) smoking cessation programs cesarean sections; 2) school-, workplace-, and in pregnancy. community-based obesity prevention For each topic, we gathered all credible evaluations we programs; 3) accountable care organizations; could locate. We screened the studies for and 4) patient cost sharing. methodological rigor and computed an average effect of the programs on specific outcomes. Where In Section III we summarize the updated possible, we then calculated benefits and costs and findings from six topics that we previously conducted a risk analysis to determine which reviewed. programs consistently have benefits that exceed costs. We found evidence that some approaches can achieve benefits that exceed costs but others do not. We explain these results in this report and display them in 1 Exhibits 2 and 3. Engrossed Substitute House Bill 1244, Chapter 564, Laws of 2009. I. Research Methods When WSIPP is asked by the Washington Next, we consider the benefits and costs of Legislature to identify “what works” and implementing a program or policy by “what does not work” on a given topic, we answering two questions: begin by locating all of the studies we can How much would it cost Washington find from around the United States and taxpayers to produce the results elsewhere. found? We analyze all high-quality studies to identify How much would it be worth to program effects. We look for research studies people in Washington State to with strong evaluation designs and exclude achieve the results found? studies with weak research methods. For That is, in dollars and cents, what are the example, to be included in our review, a study benefits and costs of each program or must have a treatment and comparison policy? group and demonstrate comparability between groups.2 Our benefit-cost results are expressed with standard financial statistics: net present We first calculate “effect sizes” for each values and benefit-cost ratios. We present study. An effect size measures the degree to monetary estimates from three perspectives: which a program has been shown to change 1) program participants, an outcome (such as diabetes incidence) for program participants relative to a 2) taxpayers, and comparison group. 3) other people in society. Our empirical approach then follows a The sum of these perspectives provides a meta-analytic framework to assess “total Washington” view on whether a systematically all credible evaluations that program or policy produces benefits that have passed our test for methodological exceed costs. rigor. Given the weight of the evidence, we calculate an average expected effect of a policy on a particular outcome of interest, as well as an estimate of the margin of error for that effect. The average effect size is a measure of the degree to which a program works. 2 Common reasons for excluding studies include treatment groups consisting solely of program completers, high study attrition rates without intent-to-treat analysis, and insufficient information reported to estimate effect sizes for outcomes of interest. 2 Benefits to individuals and society may stem In the end, we produce two “big picture” from multiple sources. For example, a policy findings for each program: an expected that reduces diabetes incidence decreases benefit-cost result and, given our the use of health care resources, thereby understanding of the risks, the probability reducing taxpayer costs and personal, out-of- that the program or policy will at least break pocket costs. In addition, preventing diabetes even. increases a person’s employment and earnings outlook. Thus, program participants We describe these methods in detail in will have higher earnings, on average, in the WSIPP’s Technical Documentation.3 labor market. Our benefit-cost model produces estimates of both the health care and labor market effects. Any tabulation of benefits and costs involves a degree of risk about the estimates calculated. This is expected in any investment analysis, whether in the private or public sector. To assess the riskiness of our conclusions, we perform a “Monte Carlo simulation” in which we vary key factors in our calculations. The purpose of this analysis is to determine the probability that a particular program or policy will have benefits that are at least equal to or greater than costs (“break even”). 3 Washington State Institute for Public Policy. (December 2015). Benefit-cost technical documentation. Olympia, WA: Author. http://www.wsipp.wa.gov/TechnicalDocumentation/WsippBe nefitCostTechnicalDocumentation.pdf 3 II. Summary of New Findings This section presents new findings for four We examined three non-clinical topics: interventions that target physicians and one additional intervention that targets patients. 1) Hospital-based interventions to We reviewed 45 studies that evaluated non- reduce cesarean sections; clinical interventions targeting physician 2) School-based, workplace-based, and behavior. Of those studies, 12 satisfied community-wide approaches to WSIPP’s methodological requirements. Two reduce obesity; of these studies evaluated the requirement 3) Accountable care organizations; and that physicians seek a second opinion 4) Patient cost sharing. before performing a C-section. Three studies evaluated requiring hospitals These topics were identified through or departments to perform an audit of consultation with Washington State C-section cases and provide feedback. legislative staff. These studies varied in the frequency of audits; the specificity of the feedback (either Evaluations of health care policies and at the department or physician-level); and programs often measure two broad types of whether information was provided outcomes: 1) those that reflect the health anonymously or publicly. status of people (e.g., disease incidence), and 2) those that reflect health care system We also reviewed seven studies that took a costs and utilization. Cost and utilization multi-faceted approach to reducing measures may or may not be an indication C-section rates. These multi-faceted of health status or well-being. approaches differed and could include audit and feedback; the implementation of clinical Benefit-cost summary statistics are in guidelines; the recruitment of local opinion Exhibit 2, while Exhibit 3 summarizes meta- leaders; and potentially other clinical or analytic results of programs for which we non-clinical interventions. did not have enough information to conduct a formal benefit-cost analysis. We find that all three of the programs targeting physicians reduce C-sections and 1) Hospital-based interventions to reduce produce benefits that consistently outweigh cesarean sections their costs. Hospital-based interventions attempt to We also reviewed one patient-targeted reduce unnecessary cesarean section (C- intervention that provides women in labor 5 section) rates by targeting physician or with continuous support from a doula, maternal behavior.4 exclude women with multiple births or complicated pregnancies, while others aim to reduce rates hospital-wide. 4 These interventions vary in the type of patients that they 5 The Doula Organization of North America (DONA) defines a target—first-time mothers, women with prior C-sections, or doula as someone who provides continuous emotional all women regardless of birth history. Some interventions reassurance and comfort for the entire labor. 4 nurse, or volunteer. From the 68 studies we We

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    20 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us